Bessemer Group’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
Bessemer Group's PPH Position: Q3 2026 in Review
Bessemer Group held its VanEck Pharmaceutical ETF (PPH) position steady in Q3 2026 at 85 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #2189.
Bessemer Group first reported a position in PPH in Q1 2026 and has held it in 3 quarters since. 155 funds tracked by Wall St. Rank hold PPH as of Q3 2026.
- Bessemer Group held 85 shares of VanEck Pharmaceutical ETF worth $9K as of Q3 2026.
- Bessemer Group left its VanEck Pharmaceutical ETF share count unchanged in Q3 2026.
- VanEck Pharmaceutical ETF made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #2189 holding.
- Bessemer Group first reported a position in VanEck Pharmaceutical ETF in Q1 2026 and has held it in 3 quarters since.
- 155 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.
Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.